Evidence map›Paper›PMID 25479235›Full record

ArticlePloS one2014

Differential expression of claudin family members during osteoblast and osteoclast differentiation: Cldn-1 is a novel positive regulator of osteoblastogenesis.

Fatima Z Alshbool, Subburaman Mohan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeted Deletion of theFrontiers in endocrinology · 2022
    Article
  4. Article
  5. Article
  6. Novel Role for Claudin-11 in the Regulation of Osteoblasts via Modulation of ADAM10-Mediated Notch Signaling.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Fatima Z AlshboolMusculoskeletal Disease Center, Jerry L Pettis VA Med Ctr, Loma Linda, CA 92357, United States of America; Department of Pharmacology, Loma Linda University, Loma Linda, CA 92354, United States of America.
Subburaman MohanMusculoskeletal Disease Center, Jerry L Pettis VA Med Ctr, Loma Linda, CA 92357, United States of America; Department of Medicine, Loma Linda University, Loma Linda, CA 92354, United States of America; Department of Biochemistry, Loma Linda University, Loma Linda, CA 92354, United States of America; Department of Physiology, Loma Linda University, Loma Linda, CA 92354, United States of America.
Loma Linda University · US

Funding

ENDOSTEAL BONE VOLUME REGULATION AND OSTEOPOROSISR01AR031062 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH &EDUC · PI MOHAN, SUBBURAMAN · 1986 to 2014
$3.5M
NIAMS NIH HHS R01 AR031062NIAMS NIH HHS R01-AR031062
6 · The paper itself

Abstract

Claudins (Cldns), a family of 27 transmembrane proteins, represent major components of tight junctions. Aside from functioning as tight junctions, Cldns have emerging roles as regulators of cell proliferation and differentiation. While Cldns are known to be expressed and have important functions in various tissues, their expression and function in bone cells is ill-defined. In this study, the expression of Cldns was examined during osteoblast and osteoclast differentiation. The expression of Cldn-1, -7, -11, and -15 was downregulated during early stages of osteoclast differentiation, whereas Cldn-6 was upregulated. Moreover, the expression of several Cldns increased 3-7 fold in fully differentiated osteoclasts. As for osteoblasts, the expression of several Cldns was found to increase more than 10-fold during differentiation, with some peaking at early, and others at late stages. By contrast, only expression of Cldn-12, and -15 decreased during osteoblast differentiation. In subsequent studies, we focused on the role of Cldn-1 in osteoblasts as its expression was increased by more than 10 fold during osteoblast differentiation and was found to be regulated by multiple osteoregulatory agents including IGF-1 and Wnt3a. We evaluated the consequence of lentiviral shRNA-mediated knockdown of Cldn-1 on osteoblast proliferation and differentiation using MC3T3-E1 mouse osteoblasts. Cldn-1 knockdown caused a significant reduction in MC3T3-E1 cell proliferation and ALP activity. Accordingly, expression levels of cyclinD1 and ALP mRNA levels were reduced in Cldn-1 shRNA knockdown cells. We next determined if Cldn-1 regulates the expression of Runx-2 and osterix, master transcription factors of osteoblast differentiation, and found that their levels were reduced significantly as a consequence of Cldn-1 knockdown. Moreover, knocking down Cldn-1 reduced β-catenin level. In conclusion, the expression of Cldn family members during bone cell differentiation is complex and involves cell type and differentiation stage-dependent regulation. In addition, Cldn-1 is a positive regulator of osteoblast proliferation and differentiation.

Indexed as

AnimalsAntigens, DifferentiationCell DifferentiationCell ProliferationClaudin-1Gene Expression RegulationInsulin-Like Growth Factor IMiceOsteoblastsOsteoclastsOsteogenesisWnt3A ProteinAntigens, DifferentiationClaudin-1Cldn1 protein, mouseinsulin-like growth factor-1, mouseInsulin-Like Growth Factor IWnt3A ProteinWnt3a protein, mouse

Identifiers

PMID25479235
PMCPMC4257558
OpenAlexW1976068969

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.